Copertina

Urticaria and angioedema in Estonia, Iceland and Sweden

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Johanna Heldin, Andrei Malinovschi, Shadi Amid Hägg, Thorarinn Gíslason, Bryndís Benediktsdóttir, Robert Movérare, Jenny Hallgren, Magnus Molin, Rain Jogi, Christer Janson
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Clinical & Experimental Allergy
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Eosinophil‐Derived Neurotoxin Determinants and Reference Values in a Swedish Middle‐Aged General Population
di: Suneela Zaigham, et al.
Pubblicazione: (2024)

Associations Between Different Eosinophil Activity Markers and Clinical Outcomes in Young Asthmatics
di: Nils Oskar Jõgi, et al.
Pubblicazione: (2026)

Airborne Microbial Signatures of Sleep Apnea Risk: Enrichment of Human‐Associated and Loss of Environmental Taxa
di: Hesham Amin, et al.
Pubblicazione: (2025)

Prediction of hereditary angioedema during attacks in patients with recurrent angioedema: Awareness at a glance with the hereditary angioedema prediction score
di: Semra Demir, et al.
Pubblicazione: (2025)

Transitional care of adolescents and young adults with asthma and allergy—The healthcare professional perspective
di: Maria Ödling, et al.
Pubblicazione: (2024)

Importance of allergic sensitisation for normal range of fractional exhaled nitric oxide in adolescents
di: Jenny Hallberg, et al.
Pubblicazione: (2025)

Advent of oral medications for the treatment of hereditary angioedema
di: Anna Valerieva, et al.
Pubblicazione: (2024)

Prodromal symptoms of hereditary angioedema (HAE) attacks: A patient survey in UK and Spain
di: Patrick F. K. Yong, et al.
Pubblicazione: (2024)

Anti‐ KIT Barzolvolimab for Chronic Spontaneous Urticaria
di: Marcus Maurer, et al.
Pubblicazione: (2025)

Decarbonising Respiratory Care: The Impact of a Low‐Carbon Salbutamol Pressurised Metered‐Dose Inhalers
di: James King, et al.
Pubblicazione: (2025)

The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria
di: T. Zuberbier, et al.
Pubblicazione: (2026)

Urticaria and Angioedema: When East Meets West—and the Middle
di: J. Peter, et al.
Pubblicazione: (2026)

Murine Model of Chronic Spontaneous Urticaria‐Like Skin
di: Yanan He, et al.
Pubblicazione: (2026)

Hereditary angioedema in children: Review and practical perspective for clinical management
di: Anne Pagnier, et al.
Pubblicazione: (2024)

Global burden of vaccine‐associated angioedema and their related vaccines, 1967–2023: Findings from the global pharmacovigilance database
di: Yi Deun Jeong, et al.
Pubblicazione: (2024)

Altered levels of phospholipases C, diacylglycerols, endocannabinoids, and N‐acylethanolamines in patients with hereditary angioedema due to FXII mutation
di: Anne Lise Ferrara, et al.
Pubblicazione: (2024)

Long‐term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open‐label extension study
di: Avner Reshef, et al.
Pubblicazione: (2024)

Assessing Risk Factors for Relapse Following Omalizumab Discontinuation in Chronic Urticaria
di: Melek Cihanbeylerden, et al.
Pubblicazione: (2024)

High‐Dimensional Analysis of Type 2 Lymphocyte Dynamics During Mepolizumab or Dupilumab Treatment in Severe Asthma
di: Lorenz Wirth, et al.
Pubblicazione: (2025)

Retrospective Analysis of Self‐Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria
di: Hazal Kayıkçı, et al.
Pubblicazione: (2025)

Effective long‐term prophylaxis with lanadelumab in adolescents with hereditary angioedema: EMPOWER / ENABLE
di: Raffi Tachdjian, et al.
Pubblicazione: (2025)

Efficacy of Omalizumab, Dupilumab, and Remibrutinib in Chronic Spontaneous Urticaria: Phase Data and Placebo Response
di: Murat Türk, et al.
Pubblicazione: (2025)

Long‐Term Efficacy and Safety of Ligelizumab as Re‐Treatment in Patients With Chronic Spontaneous Urticaria
di: Ana M. Gimenez‐Arnau, et al.
Pubblicazione: (2025)

Prevalence of Mental Health Symptoms in Chronic Urticaria: A Systematic Review and Meta‐Analysis
di: Daniel G. Rayner, et al.
Pubblicazione: (2025)

Non‐genetic factors associated with ACE‐inhibitor and angiotensin receptor blocker‐induced angioedema
di: Diana Dubrall, et al.
Pubblicazione: (2025)

How FEV 1 Improvement Induced by Anti‐ IL ‐5 in Severe Type‐2 Asthma Is Linked to Mucus Plugs Clearance
di: Alain Michils, et al.
Pubblicazione: (2024)

Increased Cardiovascular Risk in Chronic Spontaneous Urticaria: A Large Real‐World Cohort Study
di: Philip Curman, et al.
Pubblicazione: (2025)

Alterations in Gut Microbiota Composition Are Related to Disease Severity and Systemic Inflammation in Patients With Chronic Urticaria
di: Han‐Ki Park, et al.
Pubblicazione: (2025)

The Epidemiology of Chronic Urticaria in Cape Town, South Africa: A Review of Two Tertiary Referral Centers
di: Cascia Day, et al.
Pubblicazione: (2025)

Lymphopenia in Chronic Spontaneous Urticaria is Linked to Basopenia and Eosinopenia
di: Mojca Bizjak, et al.
Pubblicazione: (2024)

Disease control and quality of life in chronic spontaneous urticaria and recurrent angioedema are strongly linked, but not in all patients
di: Sophia Neisinger, et al.
Pubblicazione: (2025)

Crosslinked Fibrin Fragment (X‐ FIB ) as a Biomarker for Endotype Differentiation and Response to Omalizumab Treatment in Chronic Spontaneous Urticaria
di: Helena Port, et al.
Pubblicazione: (2025)

Exploring the Disease Duration of Urticaria and Associated Determinants in Primary Care
di: R. Soegiharto, et al.
Pubblicazione: (2025)

Rethinking Blood Biomarkers in Autoimmune Urticaria: A Response to Recent Findings
di: Sukhdeep Singh, et al.
Pubblicazione: (2024)

The Incidence of Addiction and Its Risk Factors in Chinese Chronic Urticaria Patients
di: Xinyu Shui, et al.
Pubblicazione: (2025)

Psychometric Validation of the Traditional Chinese Chronic Urticaria Quality of Life Questionnaire
di: Hugo W. F. Mak, et al.
Pubblicazione: (2024)

Perceived Acquired Resistance to Omalizumab in Obese Patients With Chronic Spontaneous Urticaria
di: Francisco Martins, et al.
Pubblicazione: (2026)

Temporal Trends in the Course and Management of Chronic Urticaria at a European Tertiary Center
di: Clara Emilie Syrene Østergaard, et al.
Pubblicazione: (2025)

Prevalence of Metabolic Syndrome in Chronic Urticaria: A Systematic Review and Meta‐Analysis
di: Daniel G. Rayner, et al.
Pubblicazione: (2025)

Serum Haptoglobin as a Predictor of Treatment Response in Patients With Chronic Spontaneous Urticaria
di: Kun‐Woo Park, et al.
Pubblicazione: (2026)